Skip to Content
Surgical Oncology Hennon MW, Kumar A, Devisetty H, et al. Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy: A Comparison Using the National Cancer Database . J Thorac Oncol. 2019;14(1):107-114. doi:10.1016/j.jtho.2018.09.024 Kawaguchi T, Yan L, Qi Q, et al. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer . Ann Surg Oncol. 2018;25(13):4037-4046. doi:10.1245/s10434-018-6859-x Nagahashi M, Shimada Y, Ichikawa H, et al. Next generation sequencing-based gene panel tests for the management of solid tumors . Cancer Sci. 2019;110(1):6-15. doi:10.1111/cas.13837 Kossenkov AV, Qureshi R, Dawany NB, et al. A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT . Cancer Res. 2019;79(1):263-273. doi:10.1158/0008-5472.CAN-18-2032 Sporn JC, Katsuta E, Yan L, Takabe K. Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients . J Surg Res. 2019;233:426-435. doi:10.1016/j.jss.2018.08.020 Hoki T, Katsuta E, Yan L, Takabe K, Ito F. Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma . J Surg Res. 2019;234:343-352. doi:10.1016/j.jss.2018.11.008 Tsuchida J, Rothman J, McDonald KA, Nagahashi M, Takabe K, Wakai T. Clinical target sequencing for precision medicine of breast cancer . Int J Clin Oncol. 2019;24(2):131-140. doi:10.1007/s10147-018-1373-5 Oyanagi H, Shimada Y, Nagahashi M, et al. SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer . Histopathology. 2019;74(6):873-882. doi:10.1111/his.13805 Cummings Iii KC, Kou TD, Chak A, et al. Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: A population-based retrospective cohort study [published correction appears in PLoS One . 2019 Mar 21;14(3):e0214528]. PLoS One. 2019;14(1):e0211125. Published 2019 Jan 22. doi:10.1371/journal.pone.0211125 Miller JA, Groman A, Yendamuri S, Hennon M. Radiation With Neoadjuvant Chemotherapy Does Not Improve Outcomes in Esophageal Squamous Cell Cancer . J Surg Res. 2019;236:259-265. doi:10.1016/j.jss.2018.11.052 Katsuta E, Qi Q, Peng X, Hochwald SN, Yan L, Takabe K. Pancreatic adenocarcinomas with mature blood vessels have better overall survival . Sci Rep. 2019;9(1):1310. Published 2019 Feb 4. doi:10.1038/s41598-018-37909-5 Yang CJ, Yendamuri S, Mayne NR, et al. The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study [published correction appears in J Thorac Cardiovasc Surg . 2019 Dec 4;:]. J Thorac Cardiovasc Surg. 2019;158(1):252-264.e2. doi:10.1016/j.jtcvs.2018.12.001 Goetz MP, Gradishar WJ, Anderson BO, et al. NCCN Guidelines Insights: Breast Cancer, Version 3 . 2018. J Natl Compr Canc Netw. 2019;17(2):118-126. doi:10.6004/jnccn.2019.0009 Reid E, Suneja G, Ambinder RF, et al. AIDS-Related Kaposi Sarcoma, Version 2 . 2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(2):171-189. doi:10.6004/jnccn.2019.0008 Shimada Y, Muneoka Y, Nagahashi M, et al. BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer . Sci Rep. 2019;9(1):2466. Published 2019 Feb 21. doi:10.1038/s41598-019-39328-6 Zhang J, Gelman IH, Katsuta E, et al. Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling . Cell Mol Gastroenterol Hepatol. 2019;8(1):37-60. doi:10.1016/j.jcmgh.2019.02.009 Peng JS, Kukar M, Mann GN, Hochwald SN. Minimally Invasive Esophageal Cancer Surgery . Surg Oncol Clin N Am. 2019;28(2):177-200. doi:10.1016/j.soc.2018.11.009 Jiang YZ, Ma D, Suo C, et al. Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies . Cancer Cell. 2019;35(3):428-440.e5. doi:10.1016/j.ccell.2019.02.001 Maddi A, Sabharwal A, Violante T, et al. The microbiome and lung cancer . J Thorac Dis. 2019;11(1):280-291. doi:10.21037/jtd.2018.12.88 Coit DG, Thompson JA, Albertini MR, et al. Cutaneous Melanoma, Version 2 . 2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(4):367-402. doi:10.6004/jnccn.2019.0018 Fountzilas C, Hochwald SN. Immune checkpoint inhibitors in esophagogastric cancer: still a long way to go . J Thorac Dis. 2019;11(2):351-353. doi:10.21037/jtd.2018.11.111 McDonald KA, Kawaguchi T, Qi Q, et al. Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients . Ann Surg Oncol. 2019;26(7):2191-2199. doi:10.1245/s10434-019-07338-3 Moro K, Nagahashi M, Gabriel E, Takabe K, Wakai T. Clinical application of ceramide in cancer treatment . Breast Cancer. 2019;26(4):407-415. doi:10.1007/s12282-019-00953-8 Mukherjee S, Hochwald SN. Pembrolizumab in advanced gastric cancer: pioneering or prosaic? . Ann Transl Med. 2019;7(Suppl 1):S3. doi:10.21037/atm.2019.01.17 Maiti A, Qi Q, Peng X, Yan L, Takabe K, Hait NC. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells . Int J Oncol. 2019;55(1):116-130. doi:10.3892/ijo.2019.4796 Patel SJ, Yamauchi T, Ito F. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy . Surg Oncol Clin N Am. 2019;28(3):489-504. doi:10.1016/j.soc.2019.02.005 Loree JT, Popat SR, Burke MS, Frustino J, Grewal JS, Loree TR. Sentinel lymph node biopsy for management of the N0 neck in oral cavity squamous cell carcinoma . J Surg Oncol. 2019;120(2):101-108. doi:10.1002/jso.25494 Okano M, Oshi M, Butash AL, et al. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival . Int J Mol Sci. 2019;20(11):2655. Published 2019 May 30. doi:10.3390/ijms20112655 Takahashi H, Katsuta E, Yan L, Dasgupta S, Takabe K. High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma . Surgery. 2019;166(2):150-156. doi:10.1016/j.surg.2019.04.011 Chapman BC, Weyant M, Hilton S, et al. Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States . Ann Thorac Surg. 2019;108(5):1535-1542. doi:10.1016/j.athoracsur.2019.05.053 Burke MS, Loree JT, Popat SR, et al. Presurgical induction chemotherapy for squamous cell carcinoma of the tonsil . Laryngoscope. 2020;130(5):1206-1211. doi:10.1002/lary.28180 Enomoto LM, Choudry MH, Bartlett DL, et al. Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection . Ann Surg Oncol. 2020;27(1):107-114. doi:10.1245/s10434-019-07634-y Yendamuri S, Barbi J, Pabla S, et al. Body Mass Index Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC . J Thorac Oncol. 2019;14(12):2181-2187. doi:10.1016/j.jtho.2019.07.020 DeGraaff LH, Platek AJ, Iovoli AJ, et al. The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma . Oral Oncol. 2019;96:148-152. doi:10.1016/j.oraloncology.2019.07.021 Liang Y, Jiang L, Zhong X, et al. Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing . Am J Med Sci. 2019;358(5):340-349. doi:10.1016/j.amjms.2019.07.012 Okano M, Oshi M, Butash AL, et al. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis . Int J Mol Sci. 2019;20(17):4197. Published 2019 Aug 27. doi:10.3390/ijms20174197 Sutphin C, Olson E, Motai Y, Lee SJ, Kim JG, Takabe K. Elastographic Tomosynthesis From X-Ray Strain Imaging of Breast Cancer . IEEE J Transl Eng Health Med. 2019;7:4300312. Published 2019 Aug 19. doi:10.1109/JTEHM.2019.2935721 Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M. Primary and secondary breast angiosarcoma: single center report and a meta-analysis . Breast Cancer Res Treat. 2019;178(3):523-533. doi:10.1007/s10549-019-05432-4 Katsuta E, Maawy AA, Yan L, Takabe K. High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor‑positive breast cancer [published online ahead of print, 2019 Aug 12] . Oncol Rep. 2019;42(4):1413-1421. doi:10.3892/or.2019.7275 Narayanan S, Kawaguchi T, Peng X, et al. Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer . Sci Rep. 2019;9(1):13455. Published 2019 Sep 17. doi:10.1038/s41598-019-49878-4 Xu Y, Wan B, Chen X, et al. The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials . Transl Lung Cancer Res. 2019;8(4):413-428. doi:10.21037/tlcr.2019.08.09 Worrell SG, Towe CW, A Dorth J, Machtay M, Perry Y, Linden PA. Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis . Ann Surg Oncol. 2020;27(2):500-508. doi:10.1245/s10434-019-07849-z Malhotra U, Mukherjee S, Fountzilas C, et al. Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates . Mol Cancer Ther. 2020;19(1):304-311. doi:10.1158/1535-7163.MCT-19-0240 Tokumaru Y, Joyce D, Takabe K. Current status and limitations of immunotherapy for breast cancer . Surgery. 2020;167(3):628-630. doi:10.1016/j.surg.2019.09.018 Uthoff RD, Song B, Sunny S, et al. Small form factor, flexible, dual-modality handheld probe for smartphone-based, point-of-care oral and oropharyngeal cancer screening . J Biomed Opt. 2019;24(10):1-8. doi:10.1117/1.JBO.24.10.106003 Dean GE, Weiss C, Jungquist CR, et al. Nurse-Delivered Brief Behavioral Treatment for Insomnia in Lung Cancer Survivors: A Pilot RCT [published online ahead of print, 2019 Oct 31] . Behav Sleep Med. 2019;1-13. doi:10.1080/15402002.2019.1685523 Asaoka M, Ishikawa T, Takabe K, Patnaik SK. APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival . Int J Mol Sci. 2019;20(22):5621. Published 2019 Nov 10. doi:10.3390/ijms20225621 Takeshita T, Yan L, Asaoka M, Rashid O, Takabe K. Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor . Sci Rep. 2019;9(1):16942. Published 2019 Nov 15. doi:10.1038/s41598-019-53482-x Takeshita T, Asaoka M, Katsuta E, et al. High expression of polo-like kinase 1 is associated with TP53 inactivation, DNA repair deficiency, and worse prognosis in ER positive Her2 negative breast cancer . Am J Transl Res. 2019;11(10):6507-6521. Published 2019 Oct 15. Demmy TL, Yendamuri S. Oncologic validity of minimally invasive lobectomy for early stage lung cancer . J Thorac Dis. 2019;11(10):E163-E167. doi:10.21037/jtd.2019.09.45 Hennon MW, DeGraaff LH, Groman A, Demmy TL, Yendamuri S. The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer . Eur J Cardiothorac Surg. 2020;57(5):888-895. doi:10.1093/ejcts/ezz320 Asaoka M, Narui K, Suganuma N, et al. Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy . Eur J Surg Oncol. 2019;45(12):2289-2294. doi:10.1016/j.ejso.2019.08.001 Ito F, Vardam TD, Appenheimer MM, et al. In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy . Int J Hyperthermia. 2019;36(sup1):22-36. doi:10.1080/02656736.2019.1653500 Peng JS, Nurkin SJ, Hochwald SN, Kukar M. Technique for Robotic Ivor Lewis Esophagectomy with 6-cm Linear Stapled Side-to-Side Anastomosis . Ann Surg Oncol. 2020;27(3):824. doi:10.1245/s10434-019-07933-4 Ettinger DS, Wood DE, Aggarwal C, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1 . 2020. J Natl Compr Canc Netw. 2019;17(12):1464-1472. doi:10.6004/jnccn.2019.0059 Baghdadi A, Aldhaam NA, Elsayed AS, et al. Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning . BJU Int. 2020;125(4):553-560. doi:10.1111/bju.14985 Katsuta E, Yan L, Takeshita T, et al. High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer . Int J Mol Sci. 2019;21(1):217. Published 2019 Dec 28. doi:10.3390/ijms21010217 Rao PK, Barker C, Coit DG, et al. NCCN Guidelines Insights: Uveal Melanoma, Version 1 . 2019. J Natl Compr Canc Netw. 2020;18(2):120-131. doi:10.6004/jnccn.2020.0007 Takahashi H, Asaoka M, Yan L, et al. Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate . Sci Rep. 2020;10(1):1852. Published 2020 Feb 5. doi:10.1038/s41598-020-58995-4 Pu CY, Yendamuri S. Neoadjuvant versus adjuvant chemotherapy for resectable non-small cell lung cancer debate revisited . J Thorac Dis. 2019;11(12):5646-5648. doi:10.21037/jtd.2019.11.23 Hennon M, Yendamuri S. For radiation therapy before surgery in esophageal cancer, dose matters, and with each answer comes more questions . J Thorac Dis. 2019;11(12):5662-5663. doi:10.21037/jtd.2019.12.62 Oshi M, Okano M, Maiti A, et al. Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies . Cancers (Basel). 2020;12(2):444. Published 2020 Feb 14. doi:10.3390/cancers12020444 Tokumaru Y, Takabe K, Yoshida K, Akao Y. Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview . Cancer Sci. 2020;111(4):1076-1083. doi:10.1111/cas.14357 Okano M, Oshi M, Butash A, et al. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts . J Mammary Gland Biol Neoplasia. 2020;25(1):27-36. doi:10.1007/s10911-020-09442-7 Kim M, Powers CA, Curtin LI, et al. A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks . J Surg Res. 2020;251:126-136. doi:10.1016/j.jss.2020.02.002 Worrell SG, Bachman KC, Sarode AL, Perry Y, Linden PA, Towe CW. Minimally invasive esophagectomy is associated with superior survival, lymphadenectomy and surgical margins: propensity matched analysis of the National Cancer Database [published online ahead of print, 2020 Mar 23] . Dis Esophagus. 2020;doaa017. doi:10.1093/dote/doaa017 Yamauchi T, Hoki T, Oba T, et al. CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment . JCI Insight. 2020;5(8):e133920. Published 2020 Apr 23. doi:10.1172/jci.insight.133920 Gradishar WJ, Anderson BO, Abraham J, et al. Breast Cancer, Version 3 . 2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(4):452-478. doi:10.6004/jnccn.2020.0016 Tokumaru Y, Oshi M, Katsuta E, et al. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival . Am J Cancer Res. 2020;10(3):897-907. Published 2020 Mar 1. Punnanitinont A, Kannisto ED, Matsuzaki J, et al. Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells . Int J Mol Sci. 2020;21(7):2573. Published 2020 Apr 7. doi:10.3390/ijms21072573 Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma . Cancer. 2020;126(11):2547-2552. doi:10.1002/cncr.32870 Asaoka M, Patnaik SK, Zhang F, Ishikawa T, Takabe K. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response . Breast Cancer Res Treat. 2020;181(2):309-322. doi:10.1007/s10549-020-05630-5 Oshi M, Takahashi H, Tokumaru Y, et al. G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer . Int J Mol Sci. 2020;21(8):2921. Published 2020 Apr 22. doi:10.3390/ijms21082921 Patnaik SK, Cortes EG, Kannisto ED, et al. Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer [published online ahead of print, 2020 Mar 23] . J Thorac Cardiovasc Surg. 2020;S0022-5223(20)30631-0. doi:10.1016/j.jtcvs.2020.01.104 Tokumaru Y, Katsuta E, Oshi M, et al. High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer . Int J Mol Sci. 2020;21(9):3045. Published 2020 Apr 26. doi:10.3390/ijms21093045 Tokumaru Y, Asaoka M, Oshi M, et al. High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer . Int J Mol Sci. 2020;21(9):3213. Published 2020 May 1. doi:10.3390/ijms21093213 Oshi M, Katsuta E, Yan L, et al. A Novel 4-Gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer . Cancers (Basel). 2020;12(5):1148. Published 2020 May 2. doi:10.3390/cancers12051148 Takahashi H, Kawaguchi T, Yan L, et al. Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma . Cancers (Basel). 2020;12(5):1221. Published 2020 May 13. doi:10.3390/cancers12051221 Takahashi H, Oshi M, Asaoka M, Yan L, Endo I, Takabe K. Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers [published online ahead of print, 2020 May 20] . Ann Surg Oncol. 2020;10.1245/s10434-020-08608-1. doi:10.1245/s10434-020-08608-1 Takahashi H, Oshi M, Asaoka M, Ishikawa T, Endo I, Takabe K. ASO Author Reflections: Transitioning From Morphology to Transcriptomics in Capturing Tumor Biology [published online ahead of print, 2020 May 29] . Ann Surg Oncol. 2020;10.1245/s10434-020-08680-7. doi:10.1245/s10434-020-08680-7 Katsuta E, Rashid OM, Takabe K. Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma . Int J Mol Sci. 2020;21(11):3890. Published 2020 May 29. doi:10.3390/ijms21113890 Katsuta E, Rashid OM, Takabe K. Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models [published online ahead of print, 2020 Jun 7] . Hum Cell. 2020;10.1007/s13577-020-00380-4. doi:10.1007/s13577-020-00380-4 Han HR, Hermann GM, Ma SJ, et al. Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patients [published online ahead of print, 2020 Jun 16] . Oral Oncol. 2020;109:104854. doi:10.1016/j.oraloncology.2020.104854 Iovoli AJ, Hermann GM, Ma SJ, et al. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy . JAMA Netw Open. 2020;3(6):e207199. Published 2020 Jun 1. doi:10.1001/jamanetworkopen.2020.7199 Gandhi S, Elkhanany A, Oshi M, et al. Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer . Int J Mol Sci. 2020;21(13):4635. Published 2020 Jun 30. doi:10.3390/ijms21134635 Jiang B, Linden PA, Gupta A, et al. Conventional Computed Tomographic Calcium Scoring vs full chest CTCS for lung cancer screening: a cost-effectiveness analysis . BMC Pulm Med. 2020;20(1):187. Published 2020 Jul 6. doi:10.1186/s12890-020-01221-8 Demmy TL. The Musician, Instrument, or Orchestra? [published online ahead of print, 2020 Jul 8] . Ann Surg Oncol. 2020;10.1245/s10434-020-08811-0. doi:10.1245/s10434-020-08811-0 Oshi M, Takahashi H, Tokumaru Y, et al. The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer . Cells. 2020;9(7):1643. Published 2020 Jul 8. doi:10.3390/cells9071643 Towe CW, Worrell SG, Bachman K, Sarode AL, Perry Y, Linden PA. Neoadjuvant treatment is associated with superior outcomes in T4 lung cancers with local extension [published online ahead of print, 2020 Jul 11] . Ann Thorac Surg. 2020;S0003-4975(20)31118-8. doi:10.1016/j.athoracsur.2020.05.084 Garg PK, Kaul P, Choudhary D, et al. Discordance of COVID-19 guidelines for patients with cancer: A systematic review [published online ahead of print, 2020 Jul 15] . J Surg Oncol. 2020;10.1002/jso.26110. doi:10.1002/jso.26110 Takahashi H, Katsuta E, Yan L, Tokumaru Y, Katz MHG, Takabe K. Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis . Cancers (Basel). 2020;12(8):E2033. Published 2020 Jul 24. doi:10.3390/cancers12082033 Dhakal A, Antony Thomas R, Levine EG, et al. Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib . Breast Cancer (Auckl). 2020;14:1178223420944864. Published 2020 Jul 23. doi:10.1177/1178223420944864 Gabriel EM, Kim M, Fisher DT, et al. Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma . Sci Rep. 2020;10(1):13245. Published 2020 Aug 6. doi:10.1038/s41598-020-70233-5 Garg PK, Kaul P, Choudhary D, Yendamuri S. Informed surgical consent during the COVID-19 pandemic: Exploring the risk of unknown [published online ahead of print, 2020 Aug 12] . J Surg Oncol. 2020;10.1002/jso.26128. doi:10.1002/jso.26128 Tokumaru Y, Oshi M, Katsuta E, et al. Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation . Int J Mol Sci. 2020;21(16):E5744. Published 2020 Aug 11. doi:10.3390/ijms21165744 Tsuchida J, Nagahashi M, Nakajima M, et al. Sphingosine Kinase 1 is Associated With Immune Cell-Related Gene Expressions in Human Breast Cancer [published online ahead of print, 2020 Aug 15] . J Surg Res. 2020;256:645-656. doi:10.1016/j.jss.2020.06.057 Oba T, Hoki T, Yamauchi T, et al. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells [published online ahead of print, 2020 Aug 26] . J Immunol. 2020;ji2000347. doi:10.4049/jimmunol.2000347
Research Funding APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO). We are an APOLLO Network Clinical Centers (CCs) within this multi-center, multi-disciplinary study group following a prospective longitudinal cohort to determine the impact of APOL1 genetic variants as susceptibility factors in US kidney transplant recipients who received kidneys from African American donors. Liise Kayler (Co-Investigator). National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK) of the National Institutes of Health. $229,964. 9/1/2017-9/1/2026. Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication. Liise Kayler (Co-Principal Investigator). NIH. $3,543,724. 8/1/2021-7/1/2025. Impact of the Increase in Availability of Ambulatory Surgery on Treatment Decision Making: A Mixed Methods Study. Jessica Martinolich (Principal Investigator). CTSI. 1/1/2024-12/1/2024.
See all recent funding>